Deferiprone is likely actively transported into milk through binding with lactoferrin.[1] Because no information is available on the use of deferiprone during breastfeeding and it is orally absorbed, an alternate drug is preferred, especially while nursing a newborn or preterm infant. Australian guidelines recommend against breastfeeding during deferiprone treatment.[2] The US manufacturer recommends withholding breastfeeding for 2 weeks after the last dose.
去铁酮可能通过与乳铁蛋白结合而被主动转运到乳汁中。[1]由于目前尚无关于哺乳期使用去铁酮的信息，且其可经口服吸收，因此首选替代药物，尤其是在哺育新生儿或早产儿期间。澳大利亚指南建议在去铁酮治疗期间不要进行母乳喂养。[2]美国制造商建议在最后一剂后停止母乳喂养2周。
